DGX News and Press, Quest Diagnostics Incorporated From 02/12/24

First PFAS "Forever Chemicals" Consumer-Initiated Blood Test with Physician Consult Launches on questhealth.com PR Newswire Directed at individuals who may be at risk of elevated PFAS exposure, the new test detects and measures PFAS identified by National Academies of Sciences...

2024-02-07 14:15:08 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Stocks ...

2024-02-07 13:23:24 ET More on S&P 500 Index: A Technical View Of Potential Downside For The Market Sterling Moves Back Into Previous Trading Range, But Will It Hold? The Warning Signs In The Stock Market Are Clear And Present (Technical Analysis) Histori...

2024-02-07 13:00:17 ET More on Quest Diagnostics Quest Diagnostics: Post-COVID Normalization Pretty Much Done Quest Diagnostics Inc. (DGX) Q4 2023 Earnings Call Transcript Quest Diagnostics: Market Overreaction Creates Investment Opportunity Quest Diagnostics...

2024-02-05 05:36:10 ET Summary Quest Diagnostics is a leading provider of diagnostic information services, offering laboratory testing, genomics, and other diagnostic solutions. During 2020, COVID-19 detection tests played an important role in the atypical growth of the top line a...

2024-02-04 06:14:22 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

2024-02-01 11:42:02 ET Quest Diagnostics Inc. (DGX) Q4 2023 Results Conference Call February 01, 2024 08:30 AM ET Company Participants Shawn Bevec - Vice President of Investor Relations Jim Davis - Chairman, Chief Executive Officer and President Sam Samad - Chief...

2024-02-01 06:50:53 ET More on Quest Diagnostics Quest Diagnostics: Market Overreaction Creates Investment Opportunity Quest Diagnostics beats top-line and bottom-line estimates; initiates FY24 outlook Quest Diagnostics Q4 2023 Earnings Preview Seeking Alpha&...

2024-02-01 06:47:51 ET More on Quest Diagnostics Quest Diagnostics: Market Overreaction Creates Investment Opportunity Quest, FitBit team up to evaluate wearables for metabolic health Seeking Alpha’s Quant Rating on Quest Diagnostics Historical earning...

Quest Diagnostics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Guidance for Full Year 2024; Increases Quarterly Dividend 5.6% to $0.75 Per Share PR Newswire Fourth quarter revenues of $2.29 billion , down 1.9% from 2022 Fourth quarter reported ...